ISSN: 2576-3881

サイトカイン生物学ジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

The Role of Cytokines and the Drugs that Block them in Acute Pancreatitis

Luis Escobar

Acute pancreatitis is an inflammation that first affects the pancreatic gland but can progress to other organs.Pathophysiological pathways connected to the systemic inflammatory response, with cytokines and oxidative stress as two of their key constituents, mediate the development of severe acute pancreatitis. The primary source of cytokines are activated leukocytes. The majority of the side effects of the systemic inflammatory response syndrome are initiated and spread by interleukin 1ß and tumour necrosis factor alpha (TNF-), which amplifies the inflammatory response. Numerous cell types create cytokines, which are low molecular weight soluble proteins, in response to stress or injury as a way of cell-to-cell communication. The primary source of cytokines, which are consequently crucial elements of the inflammatory cascade, is activated leukocytes. Interleukin 1ß (IL-1ß) and tumour necrosis factor alpha (TNF-) are two of the main members of the cytokine inflammatory family that trigger both the expression of their own cytokines as well as the expression of other cytokines, amplifying the inflammatory response. Nearly all of the effects of the systemic inflammatory response syndrome are started by and spread by these cytokines. Comparatively to those from patients without systemic problems, the monocytes from individuals with acute pancreatitis produce more TNF-, IL-6, and IL-8.